Changes in MiRNA-5196 Expression as a Potential Biomarker of Anti-TNF-Α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis Patients
Archivum Immunologiae et Therapiae Experimentalis - Switzerland
doi 10.1007/s00005-018-0513-y
Full Text
Open PDFAbstract
Available in full text
Date
May 9, 2018
Authors
Publisher
Springer Science and Business Media LLC